Mirai Medical

Ireland - GalwayBiotechnology1 H-1B visas (FY2023)

Focus: Mirai Medical is a biotechnology company based in Galway, Ireland, specializing in minimally invasive pulsed field ablation (electroporation) systems for oncology applications. The company is pre-revenue and early-stage, focused on developing novel ablation technologies across multiple cancer indications.

Oncology

Profile data last refreshed 8h ago · AI intelligence enriched 1w ago

Open Jobs

Should You Work at Mirai Medical?

AI assessment

Mirai Medical represents a high-risk, high-upside early-stage oncology device biotech play; best suited for founders, technical specialists, and risk-tolerant professionals seeking ownership in a potentially breakthrough technology before institutional scale.

Why Work Here

Opportunity to work on novel electroporation platform with Phase 3 clinical validation (calcium chloride for basal cell carcinoma) and potential near-term regulatory milestones

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

EndoVE

Oesophageal Cancer

N/A

Clinical Trials (1)

NCT04649372EndoVE endosCopic Treatment for Oesophageal and Gastric canceR

N/A

Help build intelligence for Mirai Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage biotech environment with multiple oncology indications (esophageal cancer, skin cancer, colon polyp) allows broad technical scope and ownership

100% H1B approval rate (1/1 in 2023) suggests company actively sponsors international talent and values specialized expertise

Watch Out For

Only 9 active job openings and hiring concentrated in Consulting (8 roles) and People & Culture (1 role), signaling limited current growth and potential internal constraints
Pre-revenue status with no disclosed funding, financials, or employee count creates uncertainty around runway, burn rate, and long-term career stability
Absence of publications, patent disclosures, and regulatory milestones in public data suggests early stage with limited external validation or institutional visibility

Generated by Claude from Mirai Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Irreversible Electroporation using EndoVE

Colon Polyp

N/A

Clinical Trials (1)

NCT06317727PULSed Field ablAtion of coloRectal Polyps

N/A

Electroporation for Cancer Treatment Real World Registry

Skin Cancer

N/A

Clinical Trials (1)

NCT04929912Electroporation for Cancer Treatment Real World Registry

N/A

Calcium chloride

Basal Cell Carcinoma

Phase 3

Clinical Trials (1)

NCT05046262Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Phase 3

Interview Prep Quick Facts

Portfolio: 4 clinical trials

Top TAs: Oncology

H-1B (2023): 1 approval

Open Roles: 9 active jobs

Therapeutic Area Focus

Oncology

3 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Mirai Medical

Should You Work at Mirai Medical?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (9)

Director – Management Consulting (Financial Services)

Hiring Trend

Visa Sponsorship